Biosimilar of costly inflammatory bowel disease therapy found safe and effective
Wiley Treatment of Crohn's disease and ulcerative colitis has been greatly improved by the introduction of biologic therapies such as infliximab which targets tumour necrosis factor alpha but at...
View ArticleQu Biologics Discovers Correlation Between Patient Genetics and Response to...
VANCOUVER BRITISH COLUMBIA Marketwired 030317 Qu Biologics Inc. a biopharmaceutical company developing Site Specific Immunomodulators SSIs that aim to "reboot" the body's innate immune system reports...
View ArticleMicrobiome diversity is influenced by chance encounters
Massachusetts Institute of Technology An MIT study suggests chance is an overlooked factor in the wide variation of microbe gut populations between individuals. These microbiome variations which are...
View ArticleStudy finds link between vitamin D levels and severity of malabsorption issues
Natural health experts BetterYou have welcomed a recommendation by leading gastroenterology expert Isobel Mason to take a vitamin D supplement to reduce Crohns flareups.
View ArticleNew Results from Second Phase 3 Study Show Significant Efficacy of Guselkumab...
Additional Phase 3 Study Data Show Significant Efficacy of Guselkumab in Patients Experiencing Inadequate Response to STELARAÂ in the Treatment of Moderate to Severe Plaque Psoriasis Janssen Research...
View ArticleNew lowcost biosimilar for IBD therapy shows efficacy and safety
Treatment of Crohn's disease and ulcerative colitis has been greatly improved by the introduction of biologic therapies such as infliximab which targets tumour necrosis factor alpha but at considerable...
View ArticleEpigenetic enzyme found to be lacking in some patients with Crohn's disease
A Massachusetts General Hospital MGH research team has found how a variant in an important epigenetic enzymepreviously associated by populationbased genetic studies with Crohn's disease and other...
View ArticleDoctor Consultation Online Improves Chronic Illness Patients Quality of Life...
As the healthcare landscape in the United States shifts many chronically ill Americans are left with unanswered questions. Doctor Consultation Onlines telemedicine program rises up to meet the demands...
View ArticleImmune Pharmaceuticals Inc IMNP Medical Equipment Deals and Alliances Profile...
SummaryImmune Pharmaceuticals Inc Immune Pharma formerly EpiCept Corporation is a pharmaceutical company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and...
View ArticleFirst CIMZIAÂ certolizumab pegol Study of Its Kind Showed Minimal to No...
BRUSSELS March 6 2017 PRNewswire Today UCB announced results from the CRADLE study the first lactation study designed to evaluate CIMZIAÂ certolizumab pegol concentrations in human mature breast milk...
View ArticleNovartis' Cosentyx shows almost all psoriasis patients rapidly regain skin...
EAST HANOVER N.J. March 6 2017 PRNewswire Novartis announced today a new analysis post hoc of an uncontrolled extension study which shows moderate to severe plaque psoriasis patients treated with...
View ArticleMaladie de CROHN Comment la perte d'une enzyme cl dclenche l'inflammation...
Cette équipe du Massachusetts General Hospital MGH découvre comment une variante d'une importante enzyme épigénétique interfère avec...
View ArticleLegal Cannabis Market Growth Domestically and Globally
NEW YORK March 6 2017 PRNewswire Legal cannabis sales in the United States are projected to hit $21.8 billion by 2020 assuming a compound annual growth rate of 25 according to Arcview Market Research....
View ArticleInDex Pharmaceuticals AB INDEX Financial and Strategic SWOT Analysis Review...
SummaryInDex Pharmaceuticals AB InDex Pharmaceuticals is a biopharmaceutical company that provides immunological disease treatments. The company offers Kappaproct which is in Phase III clinical trials...
View Article11 Health and Technologies Inc. Welcomes Flexpoint Sensor Systems as their...
DRAPER Utah March 7 2017 PRNewswire Flexpoint Sensor Systems Inc. FLXT and 11 Health and Technologies Inc. are excited to announce the next phase of their launch and commercialization of the 11 Health...
View ArticleNominations for 2017 Sherman Prize Now Being Accepted
NAPLES Fla. March 7 2017 PRNewswireUSNewswire The Bruce and Cynthia Sherman Charitable Foundation today announced that online nominations are now being accepted for the 2017 Sherman Prize the first...
View ArticleNorthern Colorado Doctor Kenneth Pettine Releases Information on Mesenchymal...
Dr. Kenneth Pettine a board certified retired Orthopedic Surgeon and one of the Top 50 Spine Surgeons and Specialist to Know according to Beckers Spine Review is offering to educate the public about...
View ArticleInterdisciplinary Autoimmune Summit Receives Endorsement from the AGA Institute
The Interdisciplinary Autoimmune Summit IAS the nations leading autoimmune conference and exhibition today announced that it has received endorsement from the AGA Institute the organization that runs...
View ArticleProtagonist Therapeutics Reports Fourth Quarter and YearEnd 2016 Financial...
MILPITAS Calif. March 7 2017 PRNewswire Protagonist Therapeutics Inc. NASDAQ PTGX today reported its financial results for the fourth quarter and full year ended December 31 2016 and provided an update...
View Article